Shariah compliance overview
HalalRegeneron Pharmaceuticals, Inc. (REGN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses.
Regeneron Pharmaceuticals, Inc. (REGN) operates in the Healthcare sector, in the Biotechnology industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 4.76% (limit 5%), interest-bearing debt is 2.39% (limit 30%) and interest-bearing securities and assets are 10.37% (limit 30%).
If you hold REGN, give 4.76% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 4.76%Limit 5%Pass
- Interest-bearing debt
- 2.39%Limit 30%Pass
- Interest-bearing securities and assets
- 10.37%Limit 30%Pass
- Dividend purification
- 4.76%Share of dividends to give to charityPurification calculator
Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Regeneron Pharmaceuticals, Inc. (REGN). Current Akinda screening label: Halal.
